Stan Stalnaker of Hub Culture Services Ltd. in the United Kingdom will provide the global poor, merchants and partner NGOs with easy access to digital currency for making and receiving payments or distributing aid, with no transaction costs using mobile phones. The digital currency can be exchanged for a local currency for a fee using a Gateway Broker, who can be any merchant, NGO or bank. They will develop a new open-source set of APIs (application programming interface), and simple consumer and merchant interfaces using mostly icons so that people can easily register and transfer payments.

Daniel Swale of Louisiana State University Agricultural Center in the U.S. will develop a trap to attract and kill pregnant Anopheles mosquitoes and their larvae, which transmit malaria. They will identify the best compound for attracting pregnant females based on either the known attractant Cedrol, a sugar-based attractant, or CO2. They will also test whether the larval development inhibitor triflumuron, alone or in combination with a potassium ion channel inhibitor, can be effectively transferred to the traps by mosquitoes from resting chambers, and destroy the residing larvae. The most promising combinations will be evaluated in a semi-field environment with the common malaria mosquito in southeast United States.

Curtis Vanderpuije, Kodjo Hesse and team from expressPay Ghana Ltd. in Ghana will develop a low-cost, contactless device for merchants in developing countries to more easily accept and process mobile money transactions. They will design the device so it can read identifying information from merchants and customers using radio-frequency identification, and use unstructured supplementary service data (USSD) to communicate with existing mobile money providers. Being contactless, it will speed up mobile money transactions, which currently take several minutes, and its simplicity will make it more accessible to customers. To encourage use, they will refund part of the cost of the device when a certain number of mobile money transactions are made per month.

David Wang of Washington University in St. Louis in the U.S. will evaluate specific RNA bacteriophage (viruses that infect bacteria) as therapeutics to modulate the bacterial communities in inflammatory conditions such as environmental enteropathy. To date, only DNA phage have been explored as therapeutics despite RNA phage being able to kill a broader range of bacteria. They will test the effect of two prototypical RNA phage on the gut microbe population in a mouse model of intestinal inflammation. They will also use stool samples from children with environmental enteropathy to identify novel resistance genes that block the bactericidal effect of the RNA phage, which will help gauge their value as potential therapeutics.